Literature DB >> 12696070

Near-diploid and near-triploid human sporadic colorectal adenocarcinomas differ for KRAS2 and TP53 mutational status.

Walter Giaretti1, Tiziana Venesio, Andrea Sciutto, Claudia Prevosto, Elio Geido, Mauro Risio.   

Abstract

Mutations of the KRAS2 protoncogene and inactivation of the TP53 oncosuppressor gene have been suggested to contribute to chromosomal instability (CIN) and aneuploidy in colorectal cancer (CRC). Previous work has also shown that the degree of DNA ploidy [DNA index (DI)], as obtained by flow cytometry in CRC, is non-randomly distributed and, in particular, that DI near-diploid and near-triploid values are well separated by a low-probability valley region. At present, it is not known whether a relationship exists between DI and the mutational status of KRAS2 and TP53. Multiple samples obtained from 35 human sporadic CRCs have been used to provide nuclei suspensions for flow cytometric analysis and sorting of specific DI subpopulations. Sorted nuclei were then used to analyze the high-microsatellite-instability (MSI-H) phenotype and the mutation spectrum of the KRAS2 and TP53 genes. A single MSI-H case was detected. There were 6 DNA diploid (DI = 1) and 29 aneuploid (DI not equal 1) CRCs, with the DI aneuploid cases non-randomly subdivided in 9 near-diploid (DI not equal 1 and DI </= 1.4), 8 near-triploid (1.4 < DI < 1.6), and 12 high-aneuploid (DI >/= 1.6) cases. Proximal CRCs were more often DNA diploid and near-diploid than distal ones, and Dukes' C cases were more commonly high-aneuploid than Dukes' B. Moreover, the incidence of mutations of the KRAS2 and TP53 genes was lowest among the DNA near-triploid subpopulations and highest among the near-diploid ones. We suggest that DNA near-diploid and near-triploid subpopulations in human sporadic CRC reflect different genetic mechanisms of CIN and have a potentially different clinical behavior. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12696070     DOI: 10.1002/gcc.10203

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  4 in total

1.  The inhibitory effects of 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone on human colon cancer cells.

Authors:  Peiju Qiu; Huashi Guan; Ping Dong; Shanshan Guo; Jinkai Zheng; Shiming Li; Yun Chen; Chi-Tang Ho; Min-Hsiung Pan; David Julian McClements; Hang Xiao
Journal:  Mol Nutr Food Res       Date:  2011-06-06       Impact factor: 5.914

2.  Use of multivariate analysis to suggest a new molecular classification of colorectal cancer.

Authors:  Enric Domingo; Rajarajan Ramamoorthy; Dahmane Oukrif; Daniel Rosmarin; Michal Presz; Haitao Wang; Hannah Pulker; Helen Lockstone; Tarjei Hveem; Treena Cranston; Havard Danielsen; Marco Novelli; Brian Davidson; Zheng-Zhou Xu; Peter Molloy; Elaine Johnstone; Christopher Holmes; Rachel Midgley; David Kerr; Oliver Sieber; Ian Tomlinson
Journal:  J Pathol       Date:  2013-02       Impact factor: 7.996

3.  Meta-Analysis of Cancer Triploidy: Rearrangements of Genome Complements in Male Human Tumors Are Characterized by XXY Karyotypes.

Authors:  Ninel M Vainshelbaum; Pawel Zayakin; Regina Kleina; Alessandro Giuliani; Jekaterina Erenpreisa
Journal:  Genes (Basel)       Date:  2019-08-13       Impact factor: 4.096

4.  Correlation of chromosomal instability, telomere length and telomere maintenance in microsatellite stable rectal cancer: a molecular subclass of rectal cancer.

Authors:  Lisa A Boardman; Ruth A Johnson; Kimberly B Viker; Kari A Hafner; Robert B Jenkins; Douglas L Riegert-Johnson; Thomas C Smyrk; Kristin Litzelman; Songwon Seo; Ronald E Gangnon; Corinne D Engelman; David N Rider; Russell J Vanderboom; Stephen N Thibodeau; Gloria M Petersen; Halcyon G Skinner
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.